Duloksetin: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
Muhammad Anas Sidik (bicara | kontrib)
Tidak ada ringkasan suntingan
Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
Muhammad Anas Sidik (bicara | kontrib)
Tidak ada ringkasan suntingan
Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
 
Baris 8:
 
<!--Clinical data-->
| tradename = Cymbalta, Ariclaim, Yentreve, othersdll<ref name="Drugs.com-Duloxetine-Generics"/>
| Drugs.com = {{drugs.com|monograph|duloxetine}}
| MedlinePlus = a604030
| DailyMedID = Duloxetine
| pregnancy_AU = B3
| routes_of_administration = [[Oral administration|By(rute mouthpemberian obat) |Oral]]
| class = [[Serotonin–norepinephrine reuptake inhibitor]]
| ATC_prefix = N06
Baris 29:
 
<!--Pharmacokinetic data-->
| bioavailability = ~ 50% (32% to 80%)
| protein_bound = ~ 95%
| metabolism = [[LiverHati]], twodua P450isoenzim isozymesP450, [[Sitokrom P450 2D6|CYP2D6]] and [[CYP1A2]]
| elimination_half-life = 12 hoursjam
| excretion = 70% inpada urineurin, 20% inpada fecesfeses
 
<!--Identifiers-->
Baris 66:
 
<!--Chemical data-->
| IUPAC_name = (+)-(''S'')-''N''-MethylMetil-3-(naphthalennaftalen-1-yloxyiloksi)-3-(thiophentiofen-2-ylil)propan-1-amineamina
| C=18 | H=19 | N=1 | O=1 | S=1
| smiles = CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32